Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?

Daniëlle Hijdra; Adriane D.M. Vorselaars; Heleen A. Crommelin; Coline H.M. Van Moorsel; Bob Meek; Anke M.E. Claessen; Ger T. Rijkers; Jan C. Grutters

doi:10.1183/13993003.00709-2016

Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?

Daniëlle Hijdra, Adriane D.M. Vorselaars^*, Heleen A. Crommelin, Coline H.M. Van Moorsel, Bob Meek, Anke M.E. Claessen, Ger T. Rijkers, Jan C. Grutters

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1242-1245
Number of pages	4
Journal	European Respiratory Journal
Volume	48
Issue number	4
DOIs	https://doi.org/10.1183/13993003.00709-2016
Publication status	Published - 1 Oct 2016

Access to Document

10.1183/13993003.00709-2016

Cite this

@article{3ef6e4f01ad34512baab2e91796c2f59,

title = "Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?",

author = "Dani{\"e}lle Hijdra and Vorselaars, \{Adriane D.M.\} and Crommelin, \{Heleen A.\} and \{Van Moorsel\}, \{Coline H.M.\} and Bob Meek and Claessen, \{Anke M.E.\} and Rijkers, \{Ger T.\} and Grutters, \{Jan C.\}",

year = "2016",

month = oct,

day = "1",

doi = "10.1183/13993003.00709-2016",

language = "English",

volume = "48",

pages = "1242--1245",

journal = "European Respiratory Journal",

issn = "0903-1936",